nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—Cholestasis intrahepatic—Furosemide—dilated cardiomyopathy	0.112	0.112	CcSEcCtD
Penicillamine—Pemphigoid—Furosemide—dilated cardiomyopathy	0.0936	0.0936	CcSEcCtD
Penicillamine—Pemphigus—Lisinopril—dilated cardiomyopathy	0.0459	0.0459	CcSEcCtD
Penicillamine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0351	0.0351	CcSEcCtD
Penicillamine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0333	0.0333	CcSEcCtD
Penicillamine—Red blood cell sedimentation rate increased—Lisinopril—dilated cardiomyopathy	0.0327	0.0327	CcSEcCtD
Penicillamine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0282	0.0282	CcSEcCtD
Penicillamine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0221	0.0221	CcSEcCtD
Penicillamine—Drug eruption—Furosemide—dilated cardiomyopathy	0.0191	0.0191	CcSEcCtD
Penicillamine—Eruption—Furosemide—dilated cardiomyopathy	0.0191	0.0191	CcSEcCtD
Penicillamine—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0177	0.0177	CcSEcCtD
Penicillamine—Cholestasis—Furosemide—dilated cardiomyopathy	0.0155	0.0155	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0141	0.0141	CcSEcCtD
Penicillamine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0134	0.0134	CcSEcCtD
Penicillamine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.013	0.013	CcSEcCtD
Penicillamine—Vasculitis—Furosemide—dilated cardiomyopathy	0.012	0.012	CcSEcCtD
Penicillamine—Renal failure—Spironolactone—dilated cardiomyopathy	0.0119	0.0119	CcSEcCtD
Penicillamine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0113	0.0113	CcSEcCtD
Penicillamine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.011	0.011	CcSEcCtD
Penicillamine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.01	0.01	CcSEcCtD
Penicillamine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00989	0.00989	CcSEcCtD
Penicillamine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00984	0.00984	CcSEcCtD
Penicillamine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00957	0.00957	CcSEcCtD
Penicillamine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00944	0.00944	CcSEcCtD
Penicillamine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00937	0.00937	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00903	0.00903	CcSEcCtD
Penicillamine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00902	0.00902	CcSEcCtD
Penicillamine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00844	0.00844	CcSEcCtD
Penicillamine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00827	0.00827	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00767	0.00767	CcSEcCtD
Penicillamine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00754	0.00754	CcSEcCtD
Penicillamine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00752	0.00752	CcSEcCtD
Penicillamine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00732	0.00732	CcSEcCtD
Penicillamine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00729	0.00729	CcSEcCtD
Penicillamine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00722	0.00722	CcSEcCtD
Penicillamine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00711	0.00711	CcSEcCtD
Penicillamine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00708	0.00708	CcSEcCtD
Penicillamine—Injury—Lisinopril—dilated cardiomyopathy	0.00696	0.00696	CcSEcCtD
Penicillamine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00655	0.00655	CcSEcCtD
Penicillamine—Renal failure—Furosemide—dilated cardiomyopathy	0.00645	0.00645	CcSEcCtD
Penicillamine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00621	0.00621	CcSEcCtD
Penicillamine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00613	0.00613	CcSEcCtD
Penicillamine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00612	0.00612	CcSEcCtD
Penicillamine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00609	0.00609	CcSEcCtD
Penicillamine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00582	0.00582	CcSEcCtD
Penicillamine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00578	0.00578	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00576	0.00576	CcSEcCtD
Penicillamine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00567	0.00567	CcSEcCtD
Penicillamine—Asthma—Lisinopril—dilated cardiomyopathy	0.00553	0.00553	CcSEcCtD
Penicillamine—Tinnitus—Furosemide—dilated cardiomyopathy	0.0055	0.0055	CcSEcCtD
Penicillamine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00547	0.00547	CcSEcCtD
Penicillamine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00542	0.00542	CcSEcCtD
Penicillamine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00535	0.00535	CcSEcCtD
Penicillamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00527	0.00527	CcSEcCtD
Penicillamine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00525	0.00525	CcSEcCtD
Penicillamine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00502	0.00502	CcSEcCtD
Penicillamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00489	0.00489	CcSEcCtD
Penicillamine—Rash—Spironolactone—dilated cardiomyopathy	0.00485	0.00485	CcSEcCtD
Penicillamine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00485	0.00485	CcSEcCtD
Penicillamine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00484	0.00484	CcSEcCtD
Penicillamine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00483	0.00483	CcSEcCtD
Penicillamine—Anaemia—Furosemide—dilated cardiomyopathy	0.00474	0.00474	CcSEcCtD
Penicillamine—Agitation—Furosemide—dilated cardiomyopathy	0.00472	0.00472	CcSEcCtD
Penicillamine—Haematuria—Lisinopril—dilated cardiomyopathy	0.0047	0.0047	CcSEcCtD
Penicillamine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00466	0.00466	CcSEcCtD
Penicillamine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0046	0.0046	CcSEcCtD
Penicillamine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00459	0.00459	CcSEcCtD
Penicillamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00457	0.00457	CcSEcCtD
Penicillamine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00437	0.00437	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Penicillamine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00434	0.00434	CcSEcCtD
Penicillamine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00412	0.00412	CcSEcCtD
Penicillamine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0041	0.0041	CcSEcCtD
Penicillamine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00407	0.00407	CcSEcCtD
Penicillamine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00401	0.00401	CcSEcCtD
Penicillamine—Anorexia—Furosemide—dilated cardiomyopathy	0.00399	0.00399	CcSEcCtD
Penicillamine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00391	0.00391	CcSEcCtD
Penicillamine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00387	0.00387	CcSEcCtD
Penicillamine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00377	0.00377	CcSEcCtD
Penicillamine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00364	0.00364	CcSEcCtD
Penicillamine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00356	0.00356	CcSEcCtD
Penicillamine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00345	0.00345	CcSEcCtD
Penicillamine—Urticaria—Furosemide—dilated cardiomyopathy	0.00333	0.00333	CcSEcCtD
Penicillamine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00331	0.00331	CcSEcCtD
Penicillamine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00328	0.00328	CcSEcCtD
Penicillamine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00327	0.00327	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00326	0.00326	CcSEcCtD
Penicillamine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00309	0.00309	CcSEcCtD
Penicillamine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00308	0.00308	CcSEcCtD
Penicillamine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00305	0.00305	CcSEcCtD
Penicillamine—Anorexia—Lisinopril—dilated cardiomyopathy	0.003	0.003	CcSEcCtD
Penicillamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00287	0.00287	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00286	0.00286	CcSEcCtD
Penicillamine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00273	0.00273	CcSEcCtD
Penicillamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00266	0.00266	CcSEcCtD
Penicillamine—Rash—Furosemide—dilated cardiomyopathy	0.00264	0.00264	CcSEcCtD
Penicillamine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00264	0.00264	CcSEcCtD
Penicillamine—Urticaria—Lisinopril—dilated cardiomyopathy	0.0025	0.0025	CcSEcCtD
Penicillamine—Nausea—Furosemide—dilated cardiomyopathy	0.00249	0.00249	CcSEcCtD
Penicillamine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00248	0.00248	CcSEcCtD
Penicillamine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00232	0.00232	CcSEcCtD
Penicillamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00215	0.00215	CcSEcCtD
Penicillamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.002	0.002	CcSEcCtD
Penicillamine—Rash—Lisinopril—dilated cardiomyopathy	0.00198	0.00198	CcSEcCtD
Penicillamine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00198	0.00198	CcSEcCtD
Penicillamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00187	0.00187	CcSEcCtD
